CLINICAL_TRIALS
trial_result
· 2016-07-28
Clinical Trial Update: A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas [Phase 2]
Summary
A Phase 2 randomized, placebo-controlled trial evaluated armodafinil (Nuvigil) for fatigue in patients with malignant gliomas; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eudocia Quant Lee, MD | Conditions: Malignant Glioma | Phase 2 | Status: COMPLETED | Results posted: 2016-07-28